Fundamental aspects in tumor photochemotherapy: interactions of porphyrins with membrane model systems and cells.
Some molecular aspects underlying photochemotherapy and photodiagnosis of tumors with porphyrins are reviewed. The nature of the clinically used photosensitizer HpD is first presented along with structures of molecules found to be efficient in vitro. The possible role of pH in the preferential retention of dicarboxylic porphyrins by tumors is discussed in light of results obtained with membrane models. The uptake of dicarboxylic porphyrins by cells most likely involves passive mechanisms. Cell photoinactivation using a purified porphyrin does not depend upon the incubation time but only on the intracellular concentration of the dye. This likely reflects a poor specificity of the photoinactivation processes with regard to the cellular localization of the dye. The properties which should be presented by more efficient photosensitizers are discussed.
D001798:Blood Proteins / Q000378:metabolism; D002462:Cell Membrane / Q000378:metabolism*; D002478:Cells, Cultured; D055598:Chemical Phenomena; D002621:Chemistry; D004396:Coloring Agents / Q000627:therapeutic use; D003593:Cytoplasm / Q000378:metabolism; D017324:Hematoporphyrin Derivative; D006415:Hematoporphyrins / Q000302:isolation & purification / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007700:Kinetics; D008051:Lipid Bilayers / Q000378:metabolism; D008081:Liposomes / Q000378:metabolism; D046911:Macromolecular Substances; D009369:Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D010778:Photochemotherapy; D011166:Porphyrins / Q000378:metabolism* / Q000627:therapeutic use; D013329:Structure-Activity Relationship
D001798:Blood Proteins; D004396:Coloring Agents; D006415:Hematoporphyrins; D008051:Lipid Bilayers; D008081:Liposomes; D046911:Macromolecular Substances; D011166:Porphyrins; D017324:Hematoporphyrin Derivative